title: PD-L1 in non-small-cell lung cancer: the third target for immunotherapy.
authors.affiliation: Department of Pulmonary Diseases, Vrije Universiteit VU Medical Center, 1007 MB Amsterdam, Netherlands; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address: ef.smit@vumc.nl.
authors.forename: Egbert F
authors.initials: EF
authors.lastname: Smit
authors.affiliation: Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
authors.forename: Michel M
authors.initials: MM
authors.lastname: van den Heuvel
mesh_terms: D000906:Antibodies / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D060890:B7-H1 Antigen / Q000378:metabolism*; D002289:Carcinoma, Non-Small-Cell Lung; D000077143:Docetaxel; D005260:Female; D006801:Humans; D008175:Lung Neoplasms; D008297:Male; D043823:Taxoids / Q000627:therapeutic use*
chemical_list: D000906:Antibodies; D000970:Antineoplastic Agents; D060890:B7-H1 Antigen; C423236:CD274 protein, human; D043823:Taxoids; D000077143:Docetaxel